Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Aragón (38)

2024

  1. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 821-833

  2. Colour perception develops throughout childhood with increased risk of deficiencies in children born prematurely

    Acta Paediatrica, International Journal of Paediatrics, Vol. 113, Núm. 2, pp. 259-266

  3. Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 750-758

  4. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

  5. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  6. Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment

    European Journal of Ophthalmology, Vol. 34, Núm. 4, pp. 1217-1227

  7. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  3. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  4. Influence of ocular biometric factors on the defocus curve in an enlarged depth-of-focus intraocular lens

    International Ophthalmology, Vol. 43, Núm. 3, pp. 945-955

  5. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  6. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  7. Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of health services, and mortality (DESVELA cohort): quantitative study protocol for a prospective cohort study in a hybrid analysis

    Frontiers in Public Health, Vol. 11

  8. The Research Network on Preventive Activities and Health Promotion (redIAPP): a reference network and promoter of primary care research

    Atencion Primaria, Vol. 55, Núm. 11

  9. Visual Acuity and Contrast Sensitivity in Preterm and Full-Term Children Using a Novel Digital Test

    Children, Vol. 10, Núm. 1

2022

  1. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)

    PLoS ONE, Vol. 17, Núm. 12 December

2021

  1. COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study

    Epilepsy and Behavior, Vol. 125